Edgewise Therapeutics, Inc. (EWTX)
29.06
-0.99
(-3.29%)
USD |
NASDAQ |
Mar 20, 16:00
28.60
-0.46
(-1.58%)
After-Hours: 20:00
Edgewise Therapeutics Research and Development Expense (Quarterly) : 43.07M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Glaukos Corp. | 43.65M |
| Nuvalent, Inc. | 67.80M |
| Boston Scientific Corp. | 569.00M |
| Edwards Lifesciences Corp. | 267.70M |
| Eli Lilly & Co. | 3.802B |